Steven McPhail — Chief Commercial Officer at Fluidigm Corporation

Mr. Steven C. McPhail, also known as Steve, has been the Chief Commercial Officer at Fluidigm Corporation since August 2016. Mr. McPhail served as General Manager of Production Genomics at Fluidigm Corporation since May 2015 until July 2016. Mr. McPhail served as the Chief Executive Officer of Expression Analysis, Inc. since February 2003 and also served as its President. He dedicated 12+ years to Expression Analysis. Prior to joining Expression Analysis, he served as the Executive Vice President and Chief Operating Officer of ArgoMed, Inc. He developed and implemented all company and product branding strategies. From 2000 to 2001, he increased total ArgoMed, Inc. revenue by more than 400 percent. In addition, he completed the sale of ArgoMed to ACMI Corp. in December 2002. Before his association with ArgoMed, he held senior-level sales, marketing and business development positions for Xanthon, TriPath Imaging, Dynex Technologies and Abbott Laboratories. He also has extensive experience in executing mergers and acquisitions, developing and implementing strategic marketing plans and in establishing global customer and distribution networks. He serves as a Director of Expression Analysis, Inc. He serves as Director of Improve Care Now. He serves on the board of the NC Children's Hospital and the Pediatric Inflammatory Bowel Disease Network. Mr. McPhail holds a B.S. in Biology from San Diego State University.